BCK Capital Management’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

BCK Capital Management’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,098	Closed	-$250	–	93
2023 Q1	$250	Buy	13,098 +330	+3%	+$32	﹤0.01%	72
2022 Q4	$1.9K	Hold	12,768	–	–	﹤0.01%	70
2022 Q3	$2K	Hold	12,768	–	–	﹤0.01%	84
2022 Q2	$2K	Hold	12,768	–	–	﹤0.01%	91
2022 Q1	$10K	Hold	12,768	–	–	0.01%	127
2021 Q4	$8K	Buy	+12,768	New	+$13K	0.01%	122

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

BCK Capital Management's PEARW Position: Q2 2023 in Review

BCK Capital Management sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 13,098 shares — an estimated $250 sold.

BCK Capital Management first reported a position in PEARW in Q4 2021 and held it in 6 quarters. The position peaked at $10K in Q1 2022. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

BCK Capital Management reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
BCK Capital Management sold 13,098 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $250.
BCK Capital Management first reported a position in Pear Therapeutics, Inc. Warrant in Q4 2021 and held it in 6 quarters.
BCK Capital Management's Pear Therapeutics, Inc. Warrant position peaked at $10K in Q1 2022.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on BCK Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.